Stay updated with breaking news from Caredx Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "The World Market for Molecular Diagnostics, 12th Edition" report has been added to ResearchAndMarkets.com's offering. The World Market for...
CareDx Symposium to Highlight New Real-World Use Cases Using its Testing and Digital Solutions for Improved Patient Risk Management ...
CareDx, Inc. – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and...
StockNews.com lowered shares of CareDx (NASDAQ:CDNA – Free Report) from a buy rating to a hold rating in a research report sent to investors on Wednesday morning. Several other equities analysts have also recently weighed in on CDNA. HC Wainwright reiterated a neutral rating on shares of CareDx in a research note on Wednesday, May […]
HC Wainwright reaffirmed their neutral rating on shares of CareDx (NASDAQ:CDNA – Free Report) in a report published on Friday, Benzinga reports. CDNA has been the topic of a number of other reports. StockNews.com cut CareDx from a buy rating to a hold rating in a research note on Wednesday. Raymond James downgraded CareDx from […]